U.S. flag

An official website of the United States government

NM_000162.5(GCK):c.127C>A (p.Arg43Ser) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 20, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000711760.2

Allele description [Variation Report for NM_000162.5(GCK):c.127C>A (p.Arg43Ser)]

NM_000162.5(GCK):c.127C>A (p.Arg43Ser)

Gene:
GCK:glucokinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p13
Genomic location:
Preferred name:
NM_000162.5(GCK):c.127C>A (p.Arg43Ser)
HGVS:
  • NC_000007.14:g.44153382G>T
  • NG_008847.2:g.49789C>A
  • NM_000162.5:c.127C>AMANE SELECT
  • NM_001354800.1:c.127C>A
  • NM_033507.3:c.130C>A
  • NM_033508.3:c.124C>A
  • NP_000153.1:p.Arg43Ser
  • NP_001341729.1:p.Arg43Ser
  • NP_277042.1:p.Arg44Ser
  • NP_277043.1:p.Arg42Ser
  • LRG_1074t1:c.127C>A
  • LRG_1074t2:c.130C>A
  • LRG_1074:g.49789C>A
  • LRG_1074p1:p.Arg43Ser
  • LRG_1074p2:p.Arg44Ser
  • NC_000007.13:g.44192981G>T
  • NM_000162.3:c.127C>A
Protein change:
R42S
Links:
dbSNP: rs1486280029
NCBI 1000 Genomes Browser:
rs1486280029
Molecular consequence:
  • NM_000162.5:c.127C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354800.1:c.127C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033507.3:c.130C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033508.3:c.124C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000842154Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Likely pathogenic
(Dec 20, 2017)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.

Estalella I, Rica I, Perez de Nanclares G, Bilbao JR, Vazquez JA, San Pedro JI, Busturia MA, Castaño L; Spanish MODY Group..

Clin Endocrinol (Oxf). 2007 Oct;67(4):538-46. Epub 2007 Jun 15.

PubMed [citation]
PMID:
17573900

Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis.

Beer NL, Osbak KK, van de Bunt M, Tribble ND, Steele AM, Wensley KJ, Edghill EL, Colcough K, Barrett A, Valentínová L, Rundle JK, Raimondo A, Grimsby J, Ellard S, Gloyn AL.

Diabetes Care. 2012 Jul;35(7):1482-4. doi: 10.2337/dc11-2420. Epub 2012 May 18.

PubMed [citation]
PMID:
22611063
PMCID:
PMC3379612
See all PubMed Citations (3)

Details of each submission

From Athena Diagnostics, SCV000842154.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024